Coreline Soft announced on May 13 that it has signed a distribution agreement with Incepto Medical, a leading European medical AI solution company, for its proprietary artificial intelligence (AI) software, AVIEW LCS Plus. Based on this agreement, Coreline Soft plans to expand overseas supply of its AI software by leveraging Incepto Medical's global network.
Coreline Soft entered into this agreement to expand its presence in the European market, relying on the technological competitiveness of its proprietary AI software. AVIEW LCS Plus is Coreline Soft's flagship product and has already proven its performance by being applied to government-led lung cancer screening projects in several European countries.
Incepto Medical is a France-based company specializing in the distribution and platform services of AI medical imaging solutions. The company operates its own AI platform, providing integrated AI solutions to hospitals and medical institutions. Through collaborations with numerous global AI companies, Incepto Medical has successfully established a network of over 300 medical institutions across Europe.
Starting with this new contract, Coreline Soft plans to accelerate its efforts to target the global medical AI market by continuing its collaboration with Incepto Medical. Under this agreement, Incepto Medical will be responsible for the distribution and sales of AVIEW LCS Plus in major European countries, including France. The company also explained that Incepto Medical has been expanding into markets outside Europe since establishing its U.S. subsidiary last year and plans to extend the partnership to the United States.
Coreline Soft recently demonstrated that its proprietary AI software outperformed all performance metrics compared to the products of the world's leading medical imaging diagnostics company, as published in an international academic journal. The company is also advancing its AI software through its new AI software platform, CORE:XAI.
A Coreline Soft representative said, "As our products have been adopted in government-led projects across various European countries, we have received numerous supply requests from local companies. We have decided to collaborate with Incepto Medical, which holds a leading position in the European medical AI sector," adding, "This agreement has laid the foundation for expanding our market beyond Europe to the United States."
He continued, "Since Incepto Medical not only possesses a local medical network but also collaborates with various global AI companies, we expect a significant expansion in the supply of AVIEW LCS Plus. Going forward, we will continue to work with global companies to maximize the market share of our AI software, which has proven world-class technological capabilities."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
